AYA Cancer Transitions Program
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-24
SponsorUniversity of Kansas Medical Center
About this trial
This is a single-arm, minimal-risk, interventional behavioral clinical trial embedding structured transition support for adolescent and young adult (AYA) survivors of pediatric cancer transitioning into adult-focused survivorship care. Aims are to improve AYA transition from pediatric to adult survivorship care and to enhance AYA access to fertility education and care.
Patient Participants will:
1. Complete a pre-transition developmental needs assessment 2. Receive up to 2 years of AYA nurse navigation support
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18-24 years of age at recruitment
Referral to adult survivorship clinic
Primary cancer diagnosis occurred at age 21 years or younger
English language proficiency.
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
Transitions Program
BehavioralParticipants will receive: 1. A pre-transition developmental needs assessment 2. Up to 2 years of AYA nurse navigation support
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Transitions ProgramExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Primary outcome is transition success (Goal: 80% of referred)
Medical record abstraction will be used to collect detailed information on each participant's cancer history and follow-up care. This process will include extraction of key clinical data such as cancer diagnosis, dates of treatment, treatment location, and specific treatment modalities, including radiation and chemotherapy doses. Additional information on relapse history, occurrence of secondary malignancies, and adherence to COG screening recommendations will also be obtained. Data on subspecialty referrals, scheduled appointment dates, and attendance at those appointments will be recorded to assess patterns of care and follow-up.
Time frame
Medical record abstraction at baseline and annually for 3 years.Secondary outcomes
1
Adolescent and young adult engagement and feedback
Semi-structured interviews with AYA patients will collect qualitative feedback focused on feasibility, acceptability, and utility of the program. For AYAs who do not participate in the program, interviews will inquire about barriers or reasons for non-participation. Interviews will focus on the following core topics: overall experience with pre-transition assessment and navigation, clarity and relevance of information provided, access to recommended resources and barriers, fertility education experience and referrals, self-management and transition readiness changes, suggestions to improve the program, and preferred mode/timing of contacts.
Time frame
Assessed by structured interviews at 18 & 36 mo.2
Adherence to Children's Oncology Group (COG) survivorship guidelines.
Medical record abstraction will be used to collect detailed information on each participant's cancer history and follow-up care. This process will include extraction of key clinical data such as cancer diagnosis, dates of treatment, treatment location, and specific treatment modalities, including radiation and chemotherapy doses. Additional information on relapse history, occurrence of secondary malignancies, and adherence to COG screening recommendations will also be obtained. Data on subspecialty referrals, scheduled appointment dates, and attendance at those appointments will be recorded to assess patterns of care and follow-up.
Time frame
Will be assessed by medical record abstraction at baseline, and annually for 3 years.3
Demographic and diversity-related factors of representation
The Behavioral Measurement-Based Care in Psychiatry (BMCP) Diversity Dimensions Measurement Tool is a checklist assessing demographic and diversity-related factors to examine representation. After baseline, we will shorten this measure by only including demographic factors that have potential to change over time.
Time frame
Will be assessed at baseline and years 1-3.4
Transition Readiness
The Transition Readiness Assessment Questionnaire (TRAQ13) is a questionnaire assessing preparedness for transition to adult healthcare.
Time frame
Will be measured at baseline and years 1-3.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: